The claims have alarmed defence chiefs because of the high rates of HIV/Aids in Kenya, where it affects one in 20 people. Around 10,000 British troops are deployed to Kenya every year to carry out ...

Revenue in the Sleep Aids market is projected to reach US$0.00 in 2024. Revenue is expected to show an annual growth rate (CAGR 2024-2028) of NaN%, resulting in a market volume of US$0.00 by 2028.

NAIROBI, Oct. 13 (Xinhua) -- Kenya's battle against malaria has gained new momentum through the widespread deployment of an injectable drug manufactured by the Chinese pharmaceutical company ...

it is unlikely that the Food and Drug Administration will ever approve it for longevity. The agency doesn’t consider aging to be a disease, and rapamycin’s generic status means there’s ...

Camber Pharmaceuticals shared that it has successfully launched 14 new generic drugs in the first quarter of this year. This accomplishment, with nearly one new product introduced each week ...

So you can trust that a generic medication is going to work for you just as well as the brand name medication. So when a drug manufacturer wants to bring a new medication to the market ...

Gridless, backed by Jack Dorsey's Block, operates bitcoin mines in Kenya, Malawi and Zambia. The company's bitcoin mine in Kenya, near an extinct volcano, has powered 5,000 households in the country.

The generic drug can be purchased cheaply and prescribed by most physicians and some nurses, regardless of their training. The company has received approval from the US Food and Drug ...

Skyrizi is also a biologic, a type of manmade drug created from living cells that targets inflammation. Skyrizi is not ...

(J. David Ake/Getty Images) The U.S. government is investigating whether the consolidation of health insurers, pharmacy benefit managers and pharmacies is fueling high drug costs. The Department ...

In the U.S., the FDA makes sure this happens. Once on the market, the FDA, along with the makers of the drug, continue to monitor the medicine for any unforeseen problems. Should an issue develop ...